Did You Know...
...In 1790, the cost to obtain a patent was between $4 and $5.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120108494 | INHIBITORS OF INTRACELLULAR UROKINASE PLASMINOGEN ACTIVATOR AND METHODS OF USE THEREOF The present invention provides compositions comprising amiloride amino acid and peptide conjugates. Efficient methods are also provided for administering the compositions for treating cancer and for delivering an amiloride conjugate into cancer cells in a subject in nee... | 05/03/2012 |
| 20120040964 | N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases ass... | 02/16/2012 |
| 20120035408 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorder... | 02/09/2012 |
| 20120020915 | Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System Disclosed are compounds of the general formula (I): compositions comprising an effective amount of said compounds either alone or in combination with other chemotherapeutic agents, and methods useful for trea... | 01/26/2012 |
| 20120010172 | NOVEL UREA AND THIOUREA DERIVATIVES The present application discloses compounds of formula (I) wherein X is ═O, ═S, ═NH, ═NOH and ═NO-Me; A is —C(═O)—, —S(═O)2—, —C(═S)— and P(═O)(R5)—; B is, —O—, —(CH2)3-6—, and O—(CH 01/12/2012 | |
| 20110318691 | RESIST COMPOSITION FOR SEMICONDUCTOR, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME An embodiment of the composition contains any of compounds of general formula (I) below: ... | 12/29/2011 |
| 20110313140 | PROCESS FOR PRODUCING COELENTERAMIDE OR AN ANALOG THEREOF A process for producing coelenteramide or its analog in a high yield has been desired. The invention provides a process for producing di-O-methylcoelenteramide or its analog of formula (3) which comprises rea... | 12/22/2011 |
| 20110306493 | Sulfoximinamide Compounds for Combating Animal Pests The invention relates to sulfoximinamid compounds of formula (I), to the enantiomers, diastereomers and salts thereof and to compositions comprising such compounds. The invention also relates to the use of the sulfoximinamid compounds, of their salts or of compositions ... | 12/15/2011 |
| 20110301179 | NAPHTHAMIDES AS ANTICANCER AGENTS A compound (particularly useful for inhibiting cancer) according to formula I:
| 12/08/2011 |
| 20110288280 | COELENTERAMIDE ANALOGS There has been a need for coelenteramide analogs or the like that produce fluorescent proteins which exhibit different fluorescent characteristics from those of the existing fluorescent proteins. Disclosed is a compound represented by general formula (1) (wherein R... | 11/24/2011 |
| 20110269760 | TUBULIN INHIBITORS Compounds of general formula (I), (II), (III) and (V) are described for use in modulating microtubule polymerisation and in the treatment of associated disease states. Use of compounds (I), (III) and (V) in the treatment of kinase-associated disease states is also descr... | 11/03/2011 |
| 20110251206 | Squaramide derivatives as CXCR2 antagonist The present invention relates to compounds of formula (I) wherein X, R1, R2, R3, R4 and R5 are as defined herein, which are useful for treating diseases ... | 10/13/2011 |
| 20110251204 | Modulators of G Protein-Coupled Receptor 88 The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.... | 10/13/2011 |
| 20110244481 | COELENTERAZINE ANALOGUES AND COELENTERAMIDE ANALOGUES Coelenterazine analogues with different luminescence properties from conventional ones and coelenteramide analogues with different fluorescence properties from conventional ones have been desired. The invention provides coelenterazine analogues modified at the 8-positio... | 10/06/2011 |
| 20110230497 | BIOLOGICALLY ACTIVE AMIDES The present invention is directed to biologically active amides which are ligands at the NPY Y5 receptor. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acce... | 09/22/2011 |
| 20110223093 | IONIC LIQUID SYSTEMS FOR CARBON DIOXIDE AND SULFUR DIOXIDE REMOVAL This invention relates to sulfur functionalized ionic liquid compounds that are useful in methods of carbon dioxide or sulfur dioxide removal to which they may be applied.... | 09/15/2011 |
| 20110224433 | Process for Manufacturing Substituted 3-pyridylmethyl Ammonium Bromides A process for manufacturing 5,6-disubstituted-3-pyridylmethyl ammonium bromides (I), wherein
| 09/15/2011 |
| 20110218208 | 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-h... | 09/08/2011 |
| 20110178065 | NOVEL CYP17 INHIBITORS Provided herein are inhibitors of CYP17 enzyme. Also described herein are pharmaceutical compositions that include at least one compound described herein and the use of a compound or pharmaceutical composition described herein to treat androgen-dependent diseases, disor... | 07/21/2011 |
| 20110178103 | THERAPEUTIC AGENT FOR CHRONIC RENAL FAILURE The present invention aims to provide a therapeutic agent for chronic renal failure, comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof. That is, the present invention provides provision of a... | 07/21/2011 |
| 20110178087 | Compositions and Their Use as Anti-Tumor Agents The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but ... | 07/21/2011 |
| 20110166116 | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS RELATING THERETO New compounds are disclosed which have utility in the treatment of a variety of metabolic related conditions in a patient. The compounds of this invention have the structure (I): wherein R1, R... | 07/07/2011 |
| 20110152236 | AZETIDINE POLYSUBSTITUTED COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF The invention relates to compounds of the formula (I) where: R is a (C1-C6)alkyl group, a halo(C1-C6)alkyl group; R1 is a hydrogen atom; R2 is a heteroaromatic group or a heteroaromatic(C1-C4)alkyl group,... | 06/23/2011 |
| 20110152261 | Organic compounds There are described cyclohexyl amide derivatives useful as corticotropin releasing (CRF1) receptor antagonists.... | 06/23/2011 |
| 20110144081 | PYRROLIDINE DERIVATIVES The present invention relates to compounds of formula wherein R1, R2, R3, R4, Z, and n are as defined herein | 06/16/2011 |
| 20110136828 | SUBSTITUTED N-OXIDE PYRAZINE DERIVATIVES N-oxide pyrazine derivatives represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof:
| 06/09/2011 |
| 20110124651 | FLUORINE-CONTAINING ORGANOSULFUR COMPOUND AND PESTICIDAL COMPOSITION THEREOF There is provided a fluorine-containing organosulfur compound having an excellent control effect on harmful arthropods, which is represented by the formula (I): wherein m represents 0 or 1; n represents 0, 1 or 2; A represents an optionally substituted 6-membered aromat... | 05/26/2011 |
| 20110118254 | THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE The main object of the present invention is to provide an agent for the treatment of inflammatory bowel diseases. The present invention relates to an agent for the treatment of inflammatory bowel diseases containing the heterocyclic derivat... | 05/19/2011 |
| 20110105532 | Haloalkyl-substituted amides as insecticides and acaricides The present invention relates to halogen-substituted amide derivatives of the general formula (I) in which R1 to R6, Q1 to Q8, A, V, W, X, Y, n and m are each defin... | 05/05/2011 |
| 20110105504 | Inhibitors Of 11beta-Hydroxysteroid Dehydrogenase Type 1 This invention relates to novel compounds of the Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in ma... | 05/05/2011 |
| 20110098310 | NOVEL COMPOUNDS, USE AND PREPARATION THEREOF The present invention relates to compounds of the general formula (I) wherein R1, R2 and R3 are as defined herein, which can act as inhibitors of protein kinases, specially the Fms-like tyrosine kinase 3 (FLT3). The invention also relate... | 04/28/2011 |
| 20110065710 | Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives Certain noel N-(heteroarylalkyl)alkanediamine derivatives have provided unexpected insecticidal and acaricidal activity. These compounds are represented by formula I: wherein Ar, a, r, R, Ra, Rb, Rc, Rd, b, c, Re, R... | 03/17/2011 |
| 20110065681 | AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF Compounds are provided according to formula 1: where A, B, W, X′, L, R1, R3, R4b, and m′ are as defined herein. Provided compounds and pharmaceutical compositions thereof ... | 03/17/2011 |
| 20110059957 | BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR The present invention provides a novel benzene derivative or thiophene derivative useful as a VAP-1 inhibitor, or a medicament for the prophylaxis or treatment of a VAP-1 associated disease and the like, namely, a compound represented by the formula (I): wherein each sy... | 03/10/2011 |
| 20110054174 | PROCESS FOR THE PREPARATION OF A GLUCOKINASE ACTIVATOR COMPOUND The present invention relates to a process for the preparation of a compound of formula I, wherein R1 is C1-6-alkyl and R2 is hydrogen or halogen. 03/03/2011 | |
| 20110053958 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in th... | 03/03/2011 |
| 20110046147 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES The invention relates to 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) inhibitors, the preparation thereof and the use thereof for the treatment and prophylaxis of hormone-related, especially estrogen-related or androgen-related, diseases.... | 02/24/2011 |
| 20110040091 | PROCESS FOR THE PREPARATION OF (R)-2-PHENYL PROPIONIC ACID DERIVATIVES The present invention relates to a process for the preparation of (R)-2-phenyl propionic acid derivatives of the formula wherein R1 is C1-6-alkyl and R2 is hydrogen or halogen... | 02/17/2011 |
| 20110039860 | SOLUBLE EPOXIDE HYDROLASE INHIBITORS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT Compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof is disclosed. The compounds are useful for treating diabetes, inflammation, atherosclerosis, hypertension, pain and the like. Pharmaceutical compositions and methods of use are also in... | 02/17/2011 |
| 20110028721 | Chromophore and Polymer Capable of Detecting the Presence of Various Neurotoxins and Method of Use Applicants have produced a chromophore and a polymer that are highly sensitive to the presence of various agents, including organophosphates, pesticides, neurotoxins, metal ions, some explosives, and biological toxins. The detection is accomplished by detecting a change... | 02/03/2011 |
